The relevant person in charge of Shenzhen BORUI said that the company will rely on the parent company Guangzhou Boji, make full use of the core location advantages of the International Pharmaceutical Industrial Park and the policy advantages of Shenzhen, and actively cooperate with the government to provide professional services for entrepreneurial and innovative scientists and biotechs, so as to jointly build a new height of bio-industry in Great Bay Area. 

Shenzhen Futian Biopharmaceutical Service Center is located at No.1 Haihong Road, Futian Free Trade Zone, Shenzhen. It is very advantageous in geographical location, close to the Great Bay Area sub center of NMPA (sub-CDE and sub-CMDE), and across the bank facing Shenzhen Hong Kong Science and Technology Innovation Cooperation Zone (Hong Kong Lok Ma Chau Hetao District). Innovative enterprises settled in the center have zero distance communication with angel investors and venture capital institutions, and enjoy various innovation policy dividends and supports in Shenzhen.  

Shenzhen Futian Biopharmaceutical Service Center mainly undertakes the medicinal chemistry, chemical / biological analysis (large and small molecules), in vitro and in vivo pharmacological efficacy, et. al. in the innovative drug R&D, and will strive to build a advantage platform in the fields of target verification and confirmation, introduction of cutting-edge technology into medicinal chemistry, cell / gene therapy, and translational medicine platforms.